세계의 위식도역류질환(GERD) 시장 보고서(2025년)

Gastroesophageal Reflux Disease (GERD) Global Market Report 2025

US $ 4,490 ￦ 6,181,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 8,934,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,688,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

위식도역류질환(GERD) 시장 규모는 향후 수년간 안정된 성장이 전망됩니다. 2029년에는 CAGR 2.7%로 성장할 전망이며, 59억 4,000만 달러로 성장이 예측됩니다. 예측 기간 성장은 인구 고령화, 헬스케어 지출 증가, 바이오마커 출현, 소화관 질환 스크리닝 프로그램 증가, 가슴앓이 유병률 증가, 의료기기 수요 증가 등에 기인합니다. 예측 기간 주요 동향으로는 진단 진보, 수술 진보, 표적요법 개발, 원격 의료 서비스 채용 등이 있습니다.

알코올 소비의 높은 발생률은 위식도역류질환(GERD) 시장의 성장을 가속할 것으로 예상됩니다. 알코올 섭취는 에탄올을 포함한 음료의 섭취를 의미하며, 과도하게 섭취하면 식도 운동을 낮추고 식도 압력 수준을 저하시켜 GERD 개발에 기여할 수 있습니다. 예를 들어, 2024년 7월 영국 기관인 하원 도서관은 2022년 영국 성인의 56%가 지난 1주일 동안 알코올을 섭취했다고 보고했습니다. 이 데이터로부터 음주 습관의 남녀 차이가 밝혀졌고, 이 기간에 알코올을 섭취한 적은 남성이 61%, 여성이 51%였습니다. 그 결과, 음주 습관 증가가 GERD 시장의 성장에 박차를 가하고 있습니다.

위식도역류질환(GERD) 시장에서 사업을 전개하는 유력 기업은 GERD에 대한 혁신적인 치료 장치의 도입에 주력하여 시장에서의 리더십 유지를 목표로 하고 있습니다. 예를 들면, 미국의 의료 기술 기업 Laborie Medical Technologies는 2023년 4월, 위식도역류질환(GERD)의 진단에 특화한 무선 pH 캡슐형 역류 검사 진단 시스템 alpHaONE을 발표했습니다. 이 선진적인 시스템은 최대 96시간의 포괄적인 모니터링 데이터를 제공할 수 있습니다. 특히 편리한 확대 버튼 및 신뢰성 높은 캡슐 공급 시스템을 갖춘 컴팩트하고 사용하기 쉬운 디자인을 자랑합니다. 게다가 버추얼 지시 프로그램을 갖춘 전용 소프트웨어 애플리케이션 및 유저가 증상 버튼을 커스터마이징할 수 있는 옵션도 갖추고 있어 전체적인 유저 체험을 향상시키고 있습니다. 이 혁신적인 접근은 GERD 치료 시장의 진화에 큰 영향을 주고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장-금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

• 세계의 위식도역류질환(GERD) PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
• 최종 이용 산업의 분석
• 세계의 위식도역류질환(GERD) 시장 : 성장률 분석
• 세계의 위식도역류질환(GERD) 시장 실적 : 규모 및 성장(2019-2024년)
• 세계의 위식도역류질환(GERD) 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
• 세계의 위식도역류질환(GERD) 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 위식도역류질환(GERD) 시장: 약 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 양성자 펌프 억제제
• H2 수용체 차단제
• 프로키네틱 에이전트
• 도파민 수용체 길항제
• 엔드 신치
• 스트레터
• 에소피엑스
• 경구 절개 없음 분문 성형술(TIF)
• 세계의 위식도역류질환(GERD) 시장 : 절차별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 침습적
• 저침습
• 세계의 위식도역류질환(GERD) 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 병원
• 홈케어
• 전문 클리닉
• 세계의 위식도역류질환(GERD) 시장 : 제산제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 탄산칼슘
• 수산화마그네슘
• 수산화알루미늄
• 세계의 위식도역류질환(GERD) 시장 : 양성자 펌프 억제제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 오메프라졸
• 에소메프라졸
• 란소프라졸
• 판토프라졸
• 라베프라졸
• 세계의 위식도역류질환(GERD) 시장 : H2 수용체 차단제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 라니티딘
• 파모티딘
• 니자티딘
• 시메티딘
• 세계의 위식도역류질환(GERD) 시장 : 소화관 운동 촉진제별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 메토클로프라미드
• 돈페리돈
• 세계의 위식도역류질환(GERD) 시장 : 도파민 수용체 길항제 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 프로클로르페라진
• 드로페리돌
• 세계의 위식도역류질환(GERD) 시장 : EndoCinch별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 내시경 봉합 시스템
• 세계의 위식도역류질환(GERD) 시장 : Stretta별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 고주파 어블레이션 시스템
• 세계의 위식도역류질환(GERD) 시장 : EsophyX별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 경구 분문 성형술 시스템
• 세계의 위식도역류질환(GERD) 시장 : 경구 절개 없이 분문 성형술(TIF)별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• TIF 디바이스 및 시스템

제7장 지역별 및 국가별 분석

• 세계의 위식도역류질환(GERD) 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 위식도역류질환(GERD) 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

• 위식도역류질환(GERD) 시장 : 경쟁 구도
• 위식도역류질환(GERD) 시장 : 기업 프로파일
  • GlaxoSmithKline PLC 개요, 제품 및 서비스, 전략 및 재무 분석
  • SRS Life Sciences 개요, 제품 및 서비스, 전략 및 재무 분석
  • Johnson & Johnson Services Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
  • Takeda Pharmaceutical Company Limited 개요, 제품 및 서비스, 전략 및 재무 분석
  • AstraZeneca Plc 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• Reckitt Benckiser Group Plc
• Eisai Co. Ltd.
• Pfizer Inc.
• Medtronic Plc
• Teva Pharmaceuticals
• HK inno.N Corporation
• Sebela Pharmaceuticals
• Mylan NV
• Bausch Health Companies Inc.
• Johnson & Johnson MedTech
• Eisai Co. Ltd.
• Sun Pharmaceutical Industries Ltd.
• Perrigo Company PLC
• Dr. Reddy's Laboratories Ltd.
• Aurobindo Pharma Limited

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

• 위식도역류질환(GERD) 시장 : 새로운 기회를 제공하는 국가(2029년)
• 위식도역류질환(GERD) 시장 : 새로운 기회를 제공하는 부문(2029년)
• 위식도역류질환(GERD) 시장 : 성장 전략(2029년)
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

AJY

영문 목차

영문목차

Gastroesophageal reflux disease (GERD) is a condition characterized by the regurgitation of stomach acid into the esophagus, leading to irritation and discomfort. Treating GERD involves employing a range of medical strategies and interventions to effectively manage its symptoms and associated complications.

The primary drug categories used in the treatment of gastroesophageal reflux disease include antacids, proton pump inhibitors, H2 receptor blockers, prokinetic agents, dopamine receptor antagonists, and minimally invasive procedures such as EndoCinch, Stretta, Asphyx, and Transoral Incisionless Fundoplication (TIF). Antacids, for instance, function by neutralizing stomach acid, thus increasing the stomach's pH level to alleviate symptoms. Additionally, these treatment approaches can be divided into invasive and minimally invasive procedures, offering options that cater to the unique needs of patients. These therapies are made available through various healthcare providers, including hospitals, homecare services, and specialty clinics.

The gastroesophageal reflux disease (GERD) market research report is one of a series of new reports from The Business Research Company that provides gastroesophageal reflux disease (GERD) market statistics, including gastroesophageal reflux disease (GERD) industry global market size, regional shares, competitors with a gastroesophageal reflux disease (GERD) market share, detailed gastroesophageal reflux disease (GERD) market segments, market trends and opportunities and any further data you may need to thrive in the gastroesophageal reflux disease (GERD) industry. This gastroesophageal reflux disease (GERD) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gastroesophageal reflux disease (GERD) market size has grown marginally in recent years. It will grow from $5.25 billion in 2024 to $5.35 billion in 2025 at a compound annual growth rate (CAGR) of 2.0%. The growth in the historic period can be attributed to lifestyle and dietary changes, obesity epidemic, growing awareness about gerd treatment, globalization of pharmaceutical industry, investments for gerd treatments.

The gastroesophageal reflux disease (GERD) market size is expected to see steady growth in the next few years. It will grow to $5.94 billion in 2029 at a compound annual growth rate (CAGR) of 2.7%. The growth in the forecast period can be attributed to aging population, rising healthcare spending, emergence of biomarker, growing number of screening programs for gerd, increasing prevalence of heartburn, increased demand for medical equipment. Major trends in the forecast period include diagnostic advancements, surgical advancements, development of targeted therapies, adoption of telehealth services.

The high incidence of alcohol consumption is expected to drive the growth of the gastroesophageal reflux disease (GERD) market. Alcohol consumption refers to the ingestion of beverages containing ethanol, which, when consumed in excess, can contribute to the development of GERD by reducing esophageal motility and lowering the pressure levels in the esophagus. For example, in July 2024, the House of Commons Library, a UK-based institution, reported that in 2022, 56% of adults in England had consumed alcohol in the past week. This data revealed a gender difference in drinking habits, with 61% of men and 51% of women having consumed alcohol during this period. Consequently, the increasing prevalence of alcohol consumption is fueling the growth of the GERD market.

Prominent companies operating in the gastroesophageal reflux disease (GERD) market are dedicated to the introduction of innovative treatment devices for GERD, aimed at maintaining their market leadership. For example, in April 2023, Laborie Medical Technologies, a US-based medical technology firm, unveiled the alpHaONE wireless pH-capsule reflux testing diagnostic system, designed specifically for the diagnosis of gastroesophageal reflux disease (GERD). This advanced system is capable of providing up to 96 hours of comprehensive monitoring data. Notably, it boasts a compact and user-friendly design with conveniently enlarged buttons and a dependable capsule delivery system. Moreover, it features a dedicated software application equipped with a virtual instruction program and the option for users to customize symptom buttons, thereby enhancing the overall user experience. This innovative approach is significantly impacting the evolution of the GERD treatment market.

In October 2022, Sebela Pharmaceuticals Inc., a US-based pharmaceutical company specializing in the production of gastroesophageal reflux disease medications, established a strategic partnership with HK Inno.N Corporation, a South Korea-based pharmaceutical company, in an arrangement involving an undisclosed sum. This collaboration is aimed at jointly developing and launching tegoprazan, a pioneering potassium-competitive acid blocker (P-CAB), within the US and Canada. Tegoprazan, already authorized and available in South Korea and China, holds significant promise as an innovative addition to Sebela Pharmaceuticals' gastroenterology product line, catering to individuals dealing with gastroesophageal reflux disease.

Major companies operating in the gastroesophageal reflux disease (GERD) market are GlaxoSmithKline PLC, SRS Life Sciences, Johnson & Johnson Services Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC, Reckitt Benckiser Group PLC, Eisai Co. Ltd., Pfizer Inc., Medtronic PLC, Teva Pharmaceuticals, HK inno.N Corporation, Sebela Pharmaceuticals, Mylan N.V., Bausch Health Companies Inc., Johnson & Johnson MedTech, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Ferring B.V., Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Salix Pharmaceuticals Inc., Almirall S.A., HK inno.N Corporation, SRS Life Sciences Pte. Ltd.

North America was the largest region in the gastroesophageal reflux disease (GERD) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gastroesophageal reflux disease (GERD) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gastroesophageal reflux disease (GERD) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastroesophageal reflux disease (GERD) market consists of revenues earned by entities by providing pharmaceutical therapies, surgical procedures and diagnostic tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastroesophageal reflux disease (GERD) market also includes sales of gamma-aminobutyric acid type B receptor agonists and alginate antacids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastroesophageal Reflux Disease (GERD) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastroesophageal reflux disease (gerd) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gastroesophageal reflux disease (gerd) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gastroesophageal reflux disease (gerd) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Antacids; Proton Pump Inhibitors; H2 Receptor Blocker; Pro Kinetic Agents; Dopamine Receptor Antagonist; EndoCinch; Stretta; EsophyX; Transoral Incisionless Fundoplication (TIF)
• 2) By Procedure: Invasive; Minimally Invasive
• 3) By End-Users: Hospital; Homecare; Specialty Clinics
• Subsegments:
• 1) By Antacids: Calcium Carbonate; Magnesium Hydroxide; Aluminum Hydroxide
• 2) By Proton Pump Inhibitors: Omeprazole; Esomeprazole; Lansoprazole; Pantoprazole; Rabeprazole
• 3) By H2 Receptor Blockers: Ranitidine; Famotidine; Nizatidine; Cimetidine
• 4) By Prokinetic Agents: Metoclopramide; Domperidone
• 5) By Dopamine Receptor Antagonists: Prochlorperazine; Droperidol
• 6) By EndoCinch: Endoscopic Suturing Systems
• 7) By Stretta: Radiofrequency Ablation Systems
• 8) By EsophyX: Transoral Fundoplication Systems
• 9) By Transoral Incisionless Fundoplication (TIF): TIF Devices And Systems
• Companies Mentioned: GlaxoSmithKline PLC; SRS Life Sciences; Johnson & Johnson Services Inc.; Takeda Pharmaceutical Company Limited; AstraZeneca Plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gastroesophageal Reflux Disease (GERD) Market Characteristics

3. Gastroesophageal Reflux Disease (GERD) Market Trends And Strategies

4. Gastroesophageal Reflux Disease (GERD) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Gastroesophageal Reflux Disease (GERD) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Gastroesophageal Reflux Disease (GERD) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Gastroesophageal Reflux Disease (GERD) Market Growth Rate Analysis
• 5.4. Global Gastroesophageal Reflux Disease (GERD) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Gastroesophageal Reflux Disease (GERD) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Gastroesophageal Reflux Disease (GERD) Total Addressable Market (TAM)

6. Gastroesophageal Reflux Disease (GERD) Market Segmentation

• 6.1. Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Proton Pump Inhibitors
• H2 Receptor Blocker
• Pro Kinetic Agents
• Dopamine Receptor Antagonist
• EndoCinch
• Stretta
• EsophyX
• Transoral Incisionless Fundoplication (TIF)
• 6.2. Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Invasive
• Minimally Invasive
• 6.3. Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Homecare
• Specialty Clinics
• 6.4. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Antacids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Calcium Carbonate
• Magnesium Hydroxide
• Aluminum Hydroxide
• 6.5. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Proton Pump Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Omeprazole
• Esomeprazole
• Lansoprazole
• Pantoprazole
• Rabeprazole
• 6.6. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of H2 Receptor Blockers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ranitidine
• Famotidine
• Nizatidine
• Cimetidine
• 6.7. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Prokinetic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metoclopramide
• Domperidone
• 6.8. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Dopamine Receptor Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prochlorperazine
• Droperidol
• 6.9. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of EndoCinch, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Endoscopic Suturing Systems
• 6.10. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Stretta, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radiofrequency Ablation Systems
• 6.11. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of EsophyX, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transoral Fundoplication Systems
• 6.12. Global Gastroesophageal Reflux Disease (GERD) Market, Sub-Segmentation Of Transoral Incisionless Fundoplication (TIF), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• TIF Devices And Systems

7. Gastroesophageal Reflux Disease (GERD) Market Regional And Country Analysis

• 7.1. Global Gastroesophageal Reflux Disease (GERD) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Gastroesophageal Reflux Disease (GERD) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Market

• 8.1. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gastroesophageal Reflux Disease (GERD) Market

• 9.1. China Gastroesophageal Reflux Disease (GERD) Market Overview
• 9.2. China Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gastroesophageal Reflux Disease (GERD) Market

• 10.1. India Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gastroesophageal Reflux Disease (GERD) Market

• 11.1. Japan Gastroesophageal Reflux Disease (GERD) Market Overview
• 11.2. Japan Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gastroesophageal Reflux Disease (GERD) Market

• 12.1. Australia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gastroesophageal Reflux Disease (GERD) Market

• 13.1. Indonesia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gastroesophageal Reflux Disease (GERD) Market

• 14.1. South Korea Gastroesophageal Reflux Disease (GERD) Market Overview
• 14.2. South Korea Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gastroesophageal Reflux Disease (GERD) Market

• 15.1. Western Europe Gastroesophageal Reflux Disease (GERD) Market Overview
• 15.2. Western Europe Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gastroesophageal Reflux Disease (GERD) Market

• 16.1. UK Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gastroesophageal Reflux Disease (GERD) Market

• 17.1. Germany Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gastroesophageal Reflux Disease (GERD) Market

• 18.1. France Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gastroesophageal Reflux Disease (GERD) Market

• 19.1. Italy Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gastroesophageal Reflux Disease (GERD) Market

• 20.1. Spain Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gastroesophageal Reflux Disease (GERD) Market

• 21.1. Eastern Europe Gastroesophageal Reflux Disease (GERD) Market Overview
• 21.2. Eastern Europe Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gastroesophageal Reflux Disease (GERD) Market

• 22.1. Russia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gastroesophageal Reflux Disease (GERD) Market

• 23.1. North America Gastroesophageal Reflux Disease (GERD) Market Overview
• 23.2. North America Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gastroesophageal Reflux Disease (GERD) Market

• 24.1. USA Gastroesophageal Reflux Disease (GERD) Market Overview
• 24.2. USA Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gastroesophageal Reflux Disease (GERD) Market

• 25.1. Canada Gastroesophageal Reflux Disease (GERD) Market Overview
• 25.2. Canada Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gastroesophageal Reflux Disease (GERD) Market

• 26.1. South America Gastroesophageal Reflux Disease (GERD) Market Overview
• 26.2. South America Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gastroesophageal Reflux Disease (GERD) Market

• 27.1. Brazil Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gastroesophageal Reflux Disease (GERD) Market

• 28.1. Middle East Gastroesophageal Reflux Disease (GERD) Market Overview
• 28.2. Middle East Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gastroesophageal Reflux Disease (GERD) Market

• 29.1. Africa Gastroesophageal Reflux Disease (GERD) Market Overview
• 29.2. Africa Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gastroesophageal Reflux Disease (GERD) Market Competitive Landscape And Company Profiles

• 30.1. Gastroesophageal Reflux Disease (GERD) Market Competitive Landscape
• 30.2. Gastroesophageal Reflux Disease (GERD) Market Company Profiles
  • 30.2.1. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. SRS Life Sciences Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis

31. Gastroesophageal Reflux Disease (GERD) Market Other Major And Innovative Companies

• 31.1. Reckitt Benckiser Group Plc
• 31.2. Eisai Co. Ltd.
• 31.3. Pfizer Inc.
• 31.4. Medtronic Plc
• 31.5. Teva Pharmaceuticals
• 31.6. HK inno.N Corporation
• 31.7. Sebela Pharmaceuticals
• 31.8. Mylan N.V.
• 31.9. Bausch Health Companies Inc.
• 31.10. Johnson & Johnson MedTech
• 31.11. Eisai Co. Ltd.
• 31.12. Sun Pharmaceutical Industries Ltd.
• 31.13. Perrigo Company PLC
• 31.14. Dr. Reddy's Laboratories Ltd.
• 31.15. Aurobindo Pharma Limited

32. Global Gastroesophageal Reflux Disease (GERD) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gastroesophageal Reflux Disease (GERD) Market

34. Recent Developments In The Gastroesophageal Reflux Disease (GERD) Market

35. Gastroesophageal Reflux Disease (GERD) Market High Potential Countries, Segments and Strategies

• 35.1 Gastroesophageal Reflux Disease (GERD) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Gastroesophageal Reflux Disease (GERD) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Gastroesophageal Reflux Disease (GERD) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료